Novo Nordisk A/S develops and manufactures pharmaceutical products, primarily focusing on diabetes care and hormone replacement therapies. The company operates in the areas of diabetes, obesity, hemophilia, and growth hormone therapy. Its products include insulin, GLP-1 receptor agonists, and other related medications. Novo Nordisk serves healthcare providers and patients globally, with a presence in multiple regions including Europe, North America, and Asia.
- Website
- www.novonordisk.com
- Issuer profile
- All listings